Gara Jalqabaatti › Burkitt Lymphoma › Connecticut › New Haven

Qorannoo klinikaalii Burkitt Lymphoma New Haven, CT keessatti

Qorannoo 6 Burkitt Lymphoma f New Haven fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Namoota walitti qabaa jiraSadarkaa 2

Yale University, New Haven

366 Days – 46 Years · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Namoota walitti qabaa jiraSadarkaa 3

Yale University, New Haven

Umuriin 18 hanga 39 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03150693

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Namoota walitti qabaa jiraSadarkaa 2

Yale University, New Haven

365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Namoota walitti qabaa jiraSadarkaa 1/2

Yale New Haven Hospital ( Site 1012), New Haven

6 Months – 25 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06395103

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Namoota walitti qabaa jiraSadarkaa 3

Yale University, New Haven

365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Namoota walitti qabaa jiraSadarkaa 2

Yale University School of Medicine, New Haven

Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 04-Cam-2025 · NCT03509961

Qorannoo Burkitt Lymphoma magaalota biroo keessatti

Qorannoo biroo New Haven keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.